| Ambetter Health Texas Wellcare Allwell Medicare Clinical | Vimseltinib | 2025-05-01 |
| Ambetter Health Texas Wellcare Allwell Medicare Clinical | Vismodegib | 2025-05-01 |
| Ambetter Health Texas Wellcare Allwell Medicare Clinical | Voclosporin | 2025-05-01 |
| Ambetter Health Texas Wellcare Allwell Medicare Clinical | Vutrisiran | 2025-05-01 |
| Ambetter Health Texas Wellcare Allwell Medicare Clinical | Zuranolone | 2025-05-01 |
| Ambetter Health Texas Superior Marketplace Clinical | Alirocumab | 2025-05-01 |
| Ambetter Health Texas Wellcare Allwell Medicare Clinical | Alirocumab | 2025-05-01 |
| Ambetter Health Texas Superior Marketplace Clinical | Sipuleucel-T | 2025-05-01 |
| UHC Commercial Medical & Drug | Crysvita® (Burosumab-Twza) – Commercial Medical Benefit Drug Policy | 2025-05-01 |
| UHC Commercial Medical & Drug | Parsabiv® (Etelcalcetide) – Commercial Medical Benefit Drug Policy | 2025-05-01 |